Current Status of ??-Blocking Drugs in the Treatment of Anxiety Disorders
- 1 December 1988
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 36 (6) , 773-783
- https://doi.org/10.2165/00003495-198836060-00006
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Agoraphobia, panic disorder and related conditions in the DSM-IIIR and ICD-10Journal of Psychopharmacology, 1987
- Treatment Outlines for the Management of Anxiety StatesAustralian & New Zealand Journal of Psychiatry, 1985
- Beneficial effect of nadolol on anxiety-induced disturbances of performance in musicians: A comparison with diazepam and placeboAmerican Heart Journal, 1984
- GRADUAL WITHDRAWAL OF DIAZEPAM AFTER LONG-TERM THERAPYThe Lancet, 1983
- Benzodiazepine Dependence A Review of the EvidenceDrugs, 1983
- BENZODIAZEPINE WITHDRAWAL SYMPTOMS AND PROPRANOLOLThe Lancet, 1981
- Use of β-Blocking Drugs in Psychiatry and NeurologyDrugs, 1980
- Propranolol in Neurotic and Thyrotoxic AnxietyThe British Journal of Psychiatry, 1973
- BENEFICIAL EFFECT OF BETA-ADRENERGIC BLOCKADE ON "EXAM. NERVES"The Lancet, 1972
- DRUG INHIBITION OF CATECHOLAMINE-INDUCED METABOLIC EFFECTS IN HUMANSAnnals of the New York Academy of Sciences, 1967